22:34 30-10-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
British executive accused in China drug bribery

Bishkek (AKIpress) - china-accuses-glaxosmithkline-of-enormous-and-elaborate-bribery-network Chinese police on Wednesday accused a British executive of GlaxoSmithKline of leading a sprawling scheme to bribe doctors and hospitals to use its drugs.

The announcement was the first time a foreign employee in China of British-based GSK was accused in the investigation announced last July. It highlighted the widespread use of payments to doctors and hospitals by sellers of drugs and medical equipment in a poorly funded health system that Chinese leaders have promised to improve, the AP reported.

The executive, Mark Reilly, is accused of operating a "massive bribery network," said a police official, Gao Feng, at a news conference. He said the case had been handed over to prosecutors for formal indictment, the AP said. 

Beginning in January 2009, Reilly is accused of ordering his sales team to pay doctors, hospital officials and health institutions to use GSK's products, said Gao, deputy director of the Ministry of Public Security's economic crimes unit. He said that resulted in "illegal revenue" of billions of yuan (hundreds of millions of dollars).

"GSK's bribery activities ran through its entire operations in China," Gao said.

Gao said Reilly is in China but gave no other details of his status. He said dozens of other people also were implicated but gave no names or other details.

The British Embassy in Beijing said diplomats were in regular contact with Reilly and were providing "consular assistance." The embassy declined to comment further while the case was under way.

Reilly was GSK's senior vice president of pharmaceuticals for China and Hong Kong and former general manager for China.

"We take the allegations that have been raised very seriously. They are deeply concerning to us and contrary to the values of GSK," the company said in a statement. "We want to reach a resolution that will enable the company to continue to make an important contribution to the health and welfare of China and its citizens."

Police previously identified four Chinese employees of GSK who they said confessed to bribery.

A second foreign drugmaker, AstraZeneca, said in July that police in Shanghai were investigating one of its salespeople. The company has given no information since then.

Chinese state media have publicized the bribery investigations of GSK and AstraZeneca. But economists who study Chinese health care say such payments are more widely used by China's domestic drug manufacturers.

Doctors and hospitals routinely accept informal payments from patients and suppliers of medical goods to top up low salaries and cover gaps in budgets.

Hospitals also raise money by adding surcharges to drug prices and assigning employees sales quotas. That can also distort treatment by encouraging overuse of expensive drugs or procedures.

Gao said Reilly used bribery to meet sales targets set by GSK's head office.

The company charged prices up to seven times the level charged in other countries, Gao said. He said that before a patent on one of its drugs was due to expire in 2012, GSK paid bribes to discourage hospitals from switching to cheaper generic versions.

"The more it bribed, the more drugs it could sell," he said.

GSK employees obstructed previous inquiries by bribing investigators and other government officials, Gao said.

In a separate statement, police in the central city of Changsha, where the investigation began, said Reilly and two Chinese executives also are accused of bribing government officials in Beijing and Shanghai.


Twitterfacebookprint
15:44 14.05.2014
LATEST NEWS
20:06 International donors pledge $3 billion for Aral Sea saving19:50 New electricity tariffs to become effective since January 2015 upon approval by general public – First Vice PM19:36 Small hydropower not developing in Kyrgyzstan due to long period of return of investments - Minister19:25 Power outage schedules to be approved by November, Kyrgyz government working on electricity import to avoid blackouts – Minister19:11 Construction of 14 apartment buildings for police officers planned in Kyrgyzstan19:04 Over 4,000 foreigners and stateless persons acquire citizenship of Kyrgyzstan in 201418:24 Kyrgyz government to continue legal proceedings against Latvian banker who won $16.5 million claim against it18:02 Kyrgyzstan should provide 425 villages with drinking water for 10 years – First Vice PM17:59 World Bank extends credits for over $400 million to Uzbekistan for irrigation17:53 Sweden the first EU member to recognize state of Palestine17:46 Kyrgyz government hands over equipment to rural water users associations to improve water supply17:35 Kazakhstan ready to cooperate with Russia in tightening control over transit of food products – National Economy Ministry17:24 Foreign Ministry's Envoy, Head of OSCE Field Office discuss cooperation plan for 2015, new projects in border areas17:16 7.5 billion som required annually for normal functioning of Interior Ministry – official16:39 Ukraine gas supplies in doubt as Russia seeks EU payment deal16:36 Around 400 Turkish companies active in Kyrgyzstan16:35 Almaty might become center of Islamic finance within Eurasian Economic Union - Kazakh Central Bank chief16:35 India's experience with current system of parliamentarism important for Kyrgyzstan – Central Election Commission Chairman16:31 Gold and foreign currency reserves of Kyrgyzstan grow 7.5 times over 12 years16:25 Electric Stations JSC obtains $30 million loan from Eurasian Development Bank for fuel procurement, lacks $55 million more
Astana
+1° C
Ashgabat
+12° C
Bishkek
+3° C
Dushanbe
+8° C
Tashkent
+11° C
exchange rates
 
72.95
57.33
9.20
1.34
230.21
180.87
29.60
4.23
6.34
5.00
0.82
0.12
3084.28
2367.40
385.74
61.13
3.61
2.85
0.47
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75